Infections in Patients Receiving OKT3 Monoclonal Antibody for Cardiac Rejection
Orthoclone OKT3 (muromonab-CD3), a murine monoclonal antibody that virtually eliminates circulating T cells and inhibits medullary lymphocyte function, has recently been found effective in reversing stubborn severe allograft rejection after heart transplantation. To determine the influence of OKT3 t...
שמור ב:
| הוצא לאור ב: | Tex Heart Inst J |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Texas Heart Institute
1988
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC324800/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15227260/ |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
